We are live on ! Find out more
ATHE

Alterity Therapeutics
ATHE

15 hedge funds and large institutions have $1.12M invested in Alterity Therapeutics in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $1M → $1.12M (+$118K)

0.02% less ownership

Funds ownership: 1.79% → 1.77% (-0.02%)

17% less funds holding

Funds holding: 18 → 15 (-3)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
15
Holders Change
-3
Holders Change %
-16.67%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$11.1K
2
GI
GAMMA Investing
California
+$3.61K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$18K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$9.95K
3
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$532
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$339
5
Osaic Holdings
Osaic Holdings
Arizona
-$44
Name Holding Trade Value Shares
Change 		Change in
Stake
TLCM
1
Twin Lakes Capital Management
California
$485K – – –
HWM
2
HB Wealth Management
Georgia
$203K – – –
Morgan Stanley
3
Morgan Stanley
New York
$203K -$18K -5,300 -8%
GT
4
Greenleaf Trust
Michigan
$111K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$71.5K +$11.1K +3,266 +19%
BNP Paribas Financial Markets
6
BNP Paribas Financial Markets
France
$23.7K -$339 -100 -1%
RhumbLine Advisers
7
RhumbLine Advisers
Massachusetts
$7.01K -$532 -157 -7%
GI
8
GAMMA Investing
California
$6.46K +$3.61K +1,066 +135%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$6K -$9.95K -2,936 -61%
Osaic Holdings
10
Osaic Holdings
Arizona
$240 -$44 -13 -16%
BTI
11
Blue Trust Inc
Georgia
$139 – – –
FFA
12
Farther Finance Advisors
California
$80 – – –
CA
13
CoreCap Advisors
Michigan
$73 – – –
SPIA
14
Steward Partners Investment Advisory
New York
$21 – – –
DB
15
Danske Bank
Denmark
$4 – – –
TRCT
16
Tower Research Capital (TRC)
New York
– -$31 -10 Closed
Citigroup
17
Citigroup
New York
– -$3 -1 Closed

ATHE Hedge Fund Activity: Q1 2026 in Review

15 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q1 2026, worth a combined $1.12M — up 12% from $1M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ATHE and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, adding an estimated $11.1K. The largest seller was Morgan Stanley, cutting an estimated $18K.

  • 15 institutional investors held Alterity Therapeutics (ATHE) as of Q1 2026, down from 18 in Q4 2025.
  • Funds reported $1.12M of Alterity Therapeutics stock for Q1 2026, up 12% quarter-over-quarter.
  • 0 funds opened new Alterity Therapeutics positions in Q1 2026 and 2 closed out, a net change of -2 holders.
  • The largest Alterity Therapeutics buyer in Q1 2026 was Citadel Advisors, an estimated $11.1K added.
  • The largest Alterity Therapeutics seller in Q1 2026 was Morgan Stanley, an estimated $18K sold.

Based on aggregated 13F filings for Q1 2026.